In November 2024, in the first successful private cause of action under the Anti-Foreign Sanctions Law (AFSL), a Chinese court adjudicated a civil claim by a Chinese company against its overseas customer for failure to pay...more
6/5/2025
/ Breach of Contract ,
China ,
Contract Disputes ,
Dispute Resolution ,
Economic Sanctions ,
Enforcement Actions ,
International Arbitration ,
International Trade ,
Jurisdiction ,
Office of Foreign Assets Control (OFAC) ,
SDN List
On January 10, 2025, China’s State Administration for Market Regulation (“SAMR”) put into effect its Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Compliance Guidelines”)....more
2/12/2025
/ Anti-Corruption ,
China ,
Clinical Laboratories ,
Compliance ,
Corporate Governance ,
Corruption ,
Enforcement Actions ,
Fraud ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Medical Research ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Requirements ,
Risk Management
On December 1, 2024, two key components of China’s export control regime took effect: the “Regulations on Export Control of Dual-Use Items” (“DIR”) and the “Export Control List of Dual-Use Items” (the “Dual-Use Items List”)....more
On October 11, 2024, China’s State Administration for Market Regulation (“SAMR”) issued the Draft Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Draft Guidelines”). These guidelines...more
China’s amended Law on Guarding State Secrets (“SSL”) took effect on May 1, 2024. This amendment is part of a broader legislative push to enhance national security and data protection, aligning with other recent laws such as...more